306 related articles for article (PubMed ID: 10219453)
1. Gemcitabine in the treatment of ovarian cancer.
Hansen SW; Tuxen MK; Sessa C
Ann Oncol; 1999; 10 Suppl 1():51-3. PubMed ID: 10219453
[TBL] [Abstract][Full Text] [Related]
2. Gemcitabine in the treatment of ovarian cancer.
Hansen SW
Int J Gynecol Cancer; 2001; 11 Suppl 1():39-41. PubMed ID: 11489002
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine in ovarian cancer: an overview of safety and efficacy.
Kaufmann M; von Minckwitz G
Eur J Cancer; 1997 Jan; 33 Suppl 1():S31-3. PubMed ID: 9166098
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine, platinum, and paclitaxel regimens in patients with advanced ovarian carcinoma.
Hansen SW
Semin Oncol; 2002 Feb; 29(1 Suppl 1):17-9. PubMed ID: 11840416
[TBL] [Abstract][Full Text] [Related]
5. Future directions in the chemotherapy of ovarian cancer.
Ozols RF
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-86-S15-90. PubMed ID: 9346230
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine in ovarian cancer.
Orlando M; Mandachain M
Semin Oncol; 2001 Jun; 28(3 Suppl 10):62-9. PubMed ID: 11510036
[TBL] [Abstract][Full Text] [Related]
7. Effects of sequential paclitaxel-carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study.
Wang F; Du X; Li X; Liu N; Yu H; Sheng X
Medicine (Baltimore); 2016 Dec; 95(51):e5696. PubMed ID: 28002342
[TBL] [Abstract][Full Text] [Related]
8. The role of gemcitabine in the treatment of ovarian cancer.
Ozols RF
Semin Oncol; 2000 Feb; 27(1 Suppl 2):40-7. PubMed ID: 10697035
[TBL] [Abstract][Full Text] [Related]
9. Current and future perspectives in advanced bladder cancer: is there a new standard?
von der Maase H
Semin Oncol; 2002 Feb; 29(1 Suppl 3):3-14. PubMed ID: 11894002
[TBL] [Abstract][Full Text] [Related]
10. The role of gemcitabine-based doublets in the management of ovarian carcinoma.
Thigpen T
Semin Oncol; 2002 Feb; 29(1 Suppl 1):11-6. PubMed ID: 11840415
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancer.
Friedlander M; Millward MJ; Bell D; Bugat R; Harnett P; Moreno JA; Campbell L; Varette C; Ripoche V; Kayitalire L
Ann Oncol; 1998 Dec; 9(12):1343-5. PubMed ID: 9932166
[TBL] [Abstract][Full Text] [Related]
12. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
[TBL] [Abstract][Full Text] [Related]
13. Topotecan and gemcitabine in platinum/paclitaxel-resistant ovarian cancer.
Greggi S; Salerno MG; D'Agostino G; Ferrandina G; Lorusso D; Manzione L; Mancuso S; Scambia G
Oncology; 2001; 60(1):19-23. PubMed ID: 11150903
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
Einhorn LH; Brames MJ; Juliar B; Williams SD
J Clin Oncol; 2007 Feb; 25(5):513-6. PubMed ID: 17290059
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study.
Steward WP; Dunlop DJ; Cameron C; Talbot DC; Kleisbauer JP; Thomas P; Guerin JC; Perol M; Sanson C; Dabouis G
Anticancer Drugs; 1995 Dec; 6 Suppl 6():33-7. PubMed ID: 8718423
[TBL] [Abstract][Full Text] [Related]
16. [Gemcitabine: a new chemotherapy agent for solid cancers].
Klastersky J; Awada A
Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
[TBL] [Abstract][Full Text] [Related]
17. A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer.
Gupta SK; John S; Naik R; Arora R; Selvamani B; Fuloria J; Ganesh N; Awasthy BS
Gynecol Oncol; 2005 Jul; 98(1):134-40. PubMed ID: 15894360
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients.
Lund B; Hansen OP; Theilade K; Hansen M; Neijt JP
J Natl Cancer Inst; 1994 Oct; 86(20):1530-3. PubMed ID: 7932808
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine combination chemotherapy of ovarian cancer.
Mutch DG
Gynecol Oncol; 2003 Aug; 90(2 Pt 2):S16-20. PubMed ID: 12928001
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple myeloma.
Offidani M; Mele A; Corvatta L; Marconi M; Malerba L; Olivieri A; Rupoli S; Alesiani F; Leoni P
Leuk Lymphoma; 2002 Jun; 43(6):1273-9. PubMed ID: 12152996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
